Shareholding disclosure

Banque Pictet & Cie SA

Declared position

8.87%

Threshold

Crossed upwards

Timeline

Published

07.09.2017

Transaction

31.08.2017

Voting rights breakdown

Voting rights acquired8.87%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH9500077

Beneficial owner

Banque Pictet & Cie SA

Declared address

Banque Pictet & Cie SA, Geneva

Révision de l'art. 1"0 al. 2 OIMF-FINMA et délai transitoire de l'art. 50a OIMF-FINMA .

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Banque Pictet & Cie SA

Kuros Biosciences AG07.09.2017TAH9500077

Disclosure summary

Banque Pictet & Cie SA disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 07.09.2017, at 8.87% of voting rights. Notice category: Single shareholder.

Disclosed position

8.87%

Voting rights acquired

Voting rights acquired8.87%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Banque Pictet & Cie SA disclosed a holding in Kuros Biosciences AG, published on 07.09.2017.

Publication date07.09.2017

Transaction date31.08.2017

Issuing companyKuros Biosciences AG

Beneficial ownerBanque Pictet & Cie SA

Declared addressBanque Pictet & Cie SA, Geneva

CategorySingle shareholder

Voting rights acquired8.87%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAH9500077

Conditions

Révision de l'art. 1"0 al. 2 OIMF-FINMA et délai transitoire de l'art. 50a OIMF-FINMA .

Source: SIX Exchange Regulation · Publication date: 07.09.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open